C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
167/273, 260/595
C07C 211/42 (2006.01) A61K 31/135 (2006.01) A61K 31/195 (2006.01) A61K 31/215 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2031714
R(+)-N-propargyl-1-aminoindan, its preparation and use and pharmaceutical compositions containing it. The novel compound was found to be useful for the treatment of human patients for Parkinson's disease, memory disorders, dementia of the Alzheimer type (DAT), depression and the hyperactive syndrome.
R(+)-N-propargyl-1-amino-indane; méthode de préparation et utilisation; compositions pharmaceutiques qui en renferment. Le nouveau composé s'est révélé utile pour le traitement de personnes soufrant de la maladie de Parkinson, de troubles de la mémoire, de démence de type Alzheimer, de dépression et du syndrome d'hyperactivité.
Berger-Paskin Tirtsah
Finberg John P. M.
Lerner David
Levy Ruth
Sterling Jeffrey
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Technion Research And Development Foundation Ltd.
Teva Pharmaceutical Industries Ltd.
LandOfFree
R-enantiomers of n-propargyl-1-aminoindan compounds, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with R-enantiomers of n-propargyl-1-aminoindan compounds, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and R-enantiomers of n-propargyl-1-aminoindan compounds, their... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2016396